1035099-75-2 Usage
Uses
Used in Organic Synthesis:
(4-2-[(tert-butyldimethylsilyl)oxy]ethylphenyl)boronic acid is used as a reagent for the protection of hydroxyl groups during chemical reactions, facilitating the synthesis of complex organic molecules.
Used in Materials Science:
In the field of materials science, (4-2-[(tert-butyldimethylsilyl)oxy]ethylphenyl)boronic acid is used as a building block for the development of novel materials with specific properties, such as enhanced stability or reactivity.
Used in Medicinal Chemistry:
(4-2-[(tert-butyldimethylsilyl)oxy]ethylphenyl)boronic acid is used as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs with improved efficacy and safety profiles.
Used in Agrochemicals:
In the agrochemical industry, (4-2-[(tert-butyldimethylsilyl)oxy]ethylphenyl)boronic acid is used as a component in the synthesis of various agrochemicals, such as pesticides and herbicides, to enhance their performance and selectivity.
Used in Functional Materials:
(4-2-[(tert-butyldimethylsilyl)oxy]ethylphenyl)boronic acid is employed in the creation of functional materials with tailored properties, such as sensors, catalysts, or advanced materials for energy storage and conversion applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1035099-75-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,0,9 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1035099-75:
(9*1)+(8*0)+(7*3)+(6*5)+(5*0)+(4*9)+(3*9)+(2*7)+(1*5)=142
142 % 10 = 2
So 1035099-75-2 is a valid CAS Registry Number.
1035099-75-2Relevant academic research and scientific papers
BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
-
Page/Page column 50, (2009/06/27)
Biphenyl derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the H3 histamine receptor. (Ia) Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders, such as cognitive disorders, epilepsy, brain trauma, depression, obesity, disorders of sleep and wakefulness, such as narcolepsy, shift-work syndrome, drowsiness as a side effect from a medication, maintenance of vigilance to aid in completion of tasks and the like, cataplexy, hypersomnia, somnolence syndrome, jet lag, sleep apnea and the like, attention deficit hyperactivity disorder (ADHD), schizophrenia, allergies, allergic responses in the upper airway, allergic rhinitis, nasal congestion, dementia, Alzheimer's disease, pain and the like.
